Evanthia Galanis

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.

Bradley J Erickson, Jan C Buckner, J. Buckner, 2006, Neuro-oncology.

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.

Caterina Giannini, Jan C Buckner, B. Scheithauer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Volker W Stieber, Cynthia Ménard, Jan C Buckner, 2016, JAMA.

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

Eudocia Q Lee, Benjamin M Ellingson, Timothy F Cloughesy, 2015, Clinical Cancer Research.

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

Matthew J. Maurer, Jan C. Buckner, B. Scheithauer, 2005, Investigational New Drugs.

Individualized screening trial of innovative glioblastoma therapy (INSIGhT).

Lorenzo Trippa, Keith L. Ligon, Brian M. Alexander, 2017 .

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Marion Smits, Bradley J Erickson, Jayashree Kalpathy-Cramer, 2015, Neuro-oncology.

Clinical trial end points for high-grade glioma: the evolving landscape.

Timothy F Cloughesy, Mark R Gilbert, Wolfgang Wick, 2011, Neuro-oncology.

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Lorenzo Trippa, Brian M Alexander, Paul S Mischel, 2015, Neuro-oncology.

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Mark A. Schroeder, Caterina Giannini, Jann N. Sarkaria, 2013, PloS one.

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

Caterina Giannini, Howard Gross, Chunrong Yu, 2012, Neuro-oncology.